line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,-400671785.028791,TATACHEM.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.320537,TATACHEM.NS
Normalized EBITDA,2025-03-31 00:00:00,23320000000.0,TATACHEM.NS
Total Unusual Items,2025-03-31 00:00:00,-1250000000.0,TATACHEM.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,-1250000000.0,TATACHEM.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,2020000000.0,TATACHEM.NS
Reconciled Depreciation,2025-03-31 00:00:00,11230000000.0,TATACHEM.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,52990000000.0,TATACHEM.NS
EBITDA,2025-03-31 00:00:00,22070000000.0,TATACHEM.NS
EBIT,2025-03-31 00:00:00,10840000000.0,TATACHEM.NS
Net Interest Income,2025-03-31 00:00:00,-5630000000.0,TATACHEM.NS
Interest Expense,2025-03-31 00:00:00,5630000000.0,TATACHEM.NS
Interest Income,2025-03-31 00:00:00,,TATACHEM.NS
Normalized Income,2025-03-31 00:00:00,2869328214.971209,TATACHEM.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,2350000000.0,TATACHEM.NS
Total Expenses,2025-03-31 00:00:00,140570000000.0,TATACHEM.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,TATACHEM.NS
Diluted Average Shares,2025-03-31 00:00:00,,TATACHEM.NS
Basic Average Shares,2025-03-31 00:00:00,,TATACHEM.NS
Diluted EPS,2025-03-31 00:00:00,,TATACHEM.NS
Basic EPS,2025-03-31 00:00:00,,TATACHEM.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,2350000000.0,TATACHEM.NS
Net Income Common Stockholders,2025-03-31 00:00:00,2350000000.0,TATACHEM.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,TATACHEM.NS
Net Income,2025-03-31 00:00:00,2350000000.0,TATACHEM.NS
Minority Interests,2025-03-31 00:00:00,-1520000000.0,TATACHEM.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,3870000000.0,TATACHEM.NS
Net Income Discontinuous Operations,2025-03-31 00:00:00,330000000.0,TATACHEM.NS
Net Income Continuous Operations,2025-03-31 00:00:00,3540000000.0,TATACHEM.NS
Tax Provision,2025-03-31 00:00:00,1670000000.0,TATACHEM.NS
Pretax Income,2025-03-31 00:00:00,5210000000.0,TATACHEM.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,2250000000.0,TATACHEM.NS
Special Income Charges,2025-03-31 00:00:00,-1250000000.0,TATACHEM.NS
Other Special Charges,2025-03-31 00:00:00,1250000000.0,TATACHEM.NS
Write Off,2025-03-31 00:00:00,,TATACHEM.NS
Impairment Of Capital Assets,2025-03-31 00:00:00,,TATACHEM.NS
Restructuring And Mergern Acquisition,2025-03-31 00:00:00,,TATACHEM.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-5630000000.0,TATACHEM.NS
Total Other Finance Cost,2025-03-31 00:00:00,,TATACHEM.NS
Interest Expense Non Operating,2025-03-31 00:00:00,5630000000.0,TATACHEM.NS
Interest Income Non Operating,2025-03-31 00:00:00,,TATACHEM.NS
Operating Income,2025-03-31 00:00:00,8300000000.0,TATACHEM.NS
Operating Expense,2025-03-31 00:00:00,87580000000.0,TATACHEM.NS
Other Operating Expenses,2025-03-31 00:00:00,29100000000.0,TATACHEM.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,11230000000.0,TATACHEM.NS
Amortization,2025-03-31 00:00:00,,TATACHEM.NS
Depreciation Income Statement,2025-03-31 00:00:00,11230000000.0,TATACHEM.NS
Selling General And Administration,2025-03-31 00:00:00,27360000000.0,TATACHEM.NS
Selling And Marketing Expense,2025-03-31 00:00:00,27360000000.0,TATACHEM.NS
General And Administrative Expense,2025-03-31 00:00:00,,TATACHEM.NS
Rent And Landing Fees,2025-03-31 00:00:00,,TATACHEM.NS
Gross Profit,2025-03-31 00:00:00,95880000000.0,TATACHEM.NS
Cost Of Revenue,2025-03-31 00:00:00,52990000000.0,TATACHEM.NS
Total Revenue,2025-03-31 00:00:00,148870000000.0,TATACHEM.NS
Operating Revenue,2025-03-31 00:00:00,148870000000.0,TATACHEM.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,-2583000000.0,TATACHEM.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.3,TATACHEM.NS
Normalized EBITDA,2024-03-31 00:00:00,32010000000.0,TATACHEM.NS
Total Unusual Items,2024-03-31 00:00:00,-8610000000.0,TATACHEM.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,-8610000000.0,TATACHEM.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,2820000000.0,TATACHEM.NS
Reconciled Depreciation,2024-03-31 00:00:00,9800000000.0,TATACHEM.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,53740000000.0,TATACHEM.NS
EBITDA,2024-03-31 00:00:00,23400000000.0,TATACHEM.NS
EBIT,2024-03-31 00:00:00,13600000000.0,TATACHEM.NS
Net Interest Income,2024-03-31 00:00:00,-5300000000.0,TATACHEM.NS
Interest Expense,2024-03-31 00:00:00,5300000000.0,TATACHEM.NS
Interest Income,2024-03-31 00:00:00,1410000000.0,TATACHEM.NS
Normalized Income,2024-03-31 00:00:00,8847000000.0,TATACHEM.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,2680000000.0,TATACHEM.NS
Total Expenses,2024-03-31 00:00:00,135540000000.0,TATACHEM.NS
Rent Expense Supplemental,2024-03-31 00:00:00,420000000.0,TATACHEM.NS
Diluted Average Shares,2024-03-31 00:00:00,254752852.0,TATACHEM.NS
Basic Average Shares,2024-03-31 00:00:00,254752852.0,TATACHEM.NS
Diluted EPS,2024-03-31 00:00:00,10.52,TATACHEM.NS
Basic EPS,2024-03-31 00:00:00,10.52,TATACHEM.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,2680000000.0,TATACHEM.NS
Net Income Common Stockholders,2024-03-31 00:00:00,2680000000.0,TATACHEM.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,TATACHEM.NS
Net Income,2024-03-31 00:00:00,2680000000.0,TATACHEM.NS
Minority Interests,2024-03-31 00:00:00,-1670000000.0,TATACHEM.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,4350000000.0,TATACHEM.NS
Net Income Discontinuous Operations,2024-03-31 00:00:00,-140000000.0,TATACHEM.NS
Net Income Continuous Operations,2024-03-31 00:00:00,4490000000.0,TATACHEM.NS
Tax Provision,2024-03-31 00:00:00,3810000000.0,TATACHEM.NS
Pretax Income,2024-03-31 00:00:00,8300000000.0,TATACHEM.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,2860000000.0,TATACHEM.NS
Special Income Charges,2024-03-31 00:00:00,-8610000000.0,TATACHEM.NS
Other Special Charges,2024-03-31 00:00:00,8610000000.0,TATACHEM.NS
Write Off,2024-03-31 00:00:00,270000000.0,TATACHEM.NS
Impairment Of Capital Assets,2024-03-31 00:00:00,9470000000.0,TATACHEM.NS
Restructuring And Mergern Acquisition,2024-03-31 00:00:00,,TATACHEM.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-5300000000.0,TATACHEM.NS
Total Other Finance Cost,2024-03-31 00:00:00,1000000000.0,TATACHEM.NS
Interest Expense Non Operating,2024-03-31 00:00:00,5300000000.0,TATACHEM.NS
Interest Income Non Operating,2024-03-31 00:00:00,1410000000.0,TATACHEM.NS
Operating Income,2024-03-31 00:00:00,18670000000.0,TATACHEM.NS
Operating Expense,2024-03-31 00:00:00,81800000000.0,TATACHEM.NS
Other Operating Expenses,2024-03-31 00:00:00,30720000000.0,TATACHEM.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,9800000000.0,TATACHEM.NS
Amortization,2024-03-31 00:00:00,1130000000.0,TATACHEM.NS
Depreciation Income Statement,2024-03-31 00:00:00,9800000000.0,TATACHEM.NS
Selling General And Administration,2024-03-31 00:00:00,22680000000.0,TATACHEM.NS
Selling And Marketing Expense,2024-03-31 00:00:00,22680000000.0,TATACHEM.NS
General And Administrative Expense,2024-03-31 00:00:00,1230000000.0,TATACHEM.NS
Rent And Landing Fees,2024-03-31 00:00:00,420000000.0,TATACHEM.NS
Gross Profit,2024-03-31 00:00:00,100470000000.0,TATACHEM.NS
Cost Of Revenue,2024-03-31 00:00:00,53740000000.0,TATACHEM.NS
Total Revenue,2024-03-31 00:00:00,154210000000.0,TATACHEM.NS
Operating Revenue,2024-03-31 00:00:00,154210000000.0,TATACHEM.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,36788321.167883,TATACHEM.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.105109,TATACHEM.NS
Normalized EBITDA,2023-03-31 00:00:00,39220000000.0,TATACHEM.NS
Total Unusual Items,2023-03-31 00:00:00,350000000.0,TATACHEM.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,350000000.0,TATACHEM.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,23350000000.0,TATACHEM.NS
Reconciled Depreciation,2023-03-31 00:00:00,8920000000.0,TATACHEM.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,41490000000.0,TATACHEM.NS
EBITDA,2023-03-31 00:00:00,39570000000.0,TATACHEM.NS
EBIT,2023-03-31 00:00:00,30650000000.0,TATACHEM.NS
Net Interest Income,2023-03-31 00:00:00,-3310000000.0,TATACHEM.NS
Interest Expense,2023-03-31 00:00:00,3250000000.0,TATACHEM.NS
Interest Income,2023-03-31 00:00:00,750000000.0,TATACHEM.NS
Normalized Income,2023-03-31 00:00:00,23036788321.167885,TATACHEM.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,23170000000.0,TATACHEM.NS
Total Expenses,2023-03-31 00:00:00,136890000000.0,TATACHEM.NS
Rent Expense Supplemental,2023-03-31 00:00:00,500000000.0,TATACHEM.NS
Diluted Average Shares,2023-03-31 00:00:00,254756278.0,TATACHEM.NS
Basic Average Shares,2023-03-31 00:00:00,254756278.0,TATACHEM.NS
Diluted EPS,2023-03-31 00:00:00,90.95,TATACHEM.NS
Basic EPS,2023-03-31 00:00:00,90.95,TATACHEM.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,23170000000.0,TATACHEM.NS
Net Income Common Stockholders,2023-03-31 00:00:00,23170000000.0,TATACHEM.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,TATACHEM.NS
Net Income,2023-03-31 00:00:00,23170000000.0,TATACHEM.NS
Minority Interests,2023-03-31 00:00:00,-1170000000.0,TATACHEM.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,24340000000.0,TATACHEM.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,-180000000.0,TATACHEM.NS
Net Income Continuous Operations,2023-03-31 00:00:00,24520000000.0,TATACHEM.NS
Tax Provision,2023-03-31 00:00:00,2880000000.0,TATACHEM.NS
Pretax Income,2023-03-31 00:00:00,27400000000.0,TATACHEM.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,360000000.0,TATACHEM.NS
Special Income Charges,2023-03-31 00:00:00,-220000000.0,TATACHEM.NS
Other Special Charges,2023-03-31 00:00:00,190000000.0,TATACHEM.NS
Write Off,2023-03-31 00:00:00,30000000.0,TATACHEM.NS
Impairment Of Capital Assets,2023-03-31 00:00:00,,TATACHEM.NS
Restructuring And Mergern Acquisition,2023-03-31 00:00:00,,TATACHEM.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-3310000000.0,TATACHEM.NS
Total Other Finance Cost,2023-03-31 00:00:00,810000000.0,TATACHEM.NS
Interest Expense Non Operating,2023-03-31 00:00:00,3250000000.0,TATACHEM.NS
Interest Income Non Operating,2023-03-31 00:00:00,750000000.0,TATACHEM.NS
Operating Income,2023-03-31 00:00:00,29910000000.0,TATACHEM.NS
Operating Expense,2023-03-31 00:00:00,95400000000.0,TATACHEM.NS
Other Operating Expenses,2023-03-31 00:00:00,42630000000.0,TATACHEM.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,8920000000.0,TATACHEM.NS
Amortization,2023-03-31 00:00:00,1090000000.0,TATACHEM.NS
Depreciation Income Statement,2023-03-31 00:00:00,7830000000.0,TATACHEM.NS
Selling General And Administration,2023-03-31 00:00:00,27470000000.0,TATACHEM.NS
Selling And Marketing Expense,2023-03-31 00:00:00,26420000000.0,TATACHEM.NS
General And Administrative Expense,2023-03-31 00:00:00,1050000000.0,TATACHEM.NS
Rent And Landing Fees,2023-03-31 00:00:00,500000000.0,TATACHEM.NS
Gross Profit,2023-03-31 00:00:00,125310000000.0,TATACHEM.NS
Cost Of Revenue,2023-03-31 00:00:00,41490000000.0,TATACHEM.NS
Total Revenue,2023-03-31 00:00:00,166800000000.0,TATACHEM.NS
Operating Revenue,2023-03-31 00:00:00,166800000000.0,TATACHEM.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,52855428.914217,TATACHEM.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.160168,TATACHEM.NS
Normalized EBITDA,2022-03-31 00:00:00,26670000000.0,TATACHEM.NS
Total Unusual Items,2022-03-31 00:00:00,330000000.0,TATACHEM.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,330000000.0,TATACHEM.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,12530000000.0,TATACHEM.NS
Reconciled Depreciation,2022-03-31 00:00:00,8060000000.0,TATACHEM.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,32880000000.0,TATACHEM.NS
EBITDA,2022-03-31 00:00:00,27000000000.0,TATACHEM.NS
EBIT,2022-03-31 00:00:00,18940000000.0,TATACHEM.NS
Net Interest Income,2022-03-31 00:00:00,-1880000000.0,TATACHEM.NS
Interest Expense,2022-03-31 00:00:00,2270000000.0,TATACHEM.NS
Interest Income,2022-03-31 00:00:00,1150000000.0,TATACHEM.NS
Normalized Income,2022-03-31 00:00:00,12252855428.914217,TATACHEM.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,12580000000.0,TATACHEM.NS
Total Expenses,2022-03-31 00:00:00,109790000000.0,TATACHEM.NS
Rent Expense Supplemental,2022-03-31 00:00:00,430000000.0,TATACHEM.NS
Diluted Average Shares,2022-03-31 00:00:00,254756278.0,TATACHEM.NS
Basic Average Shares,2022-03-31 00:00:00,254756278.0,TATACHEM.NS
Diluted EPS,2022-03-31 00:00:00,49.37,TATACHEM.NS
Basic EPS,2022-03-31 00:00:00,49.37,TATACHEM.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,12580000000.0,TATACHEM.NS
Net Income Common Stockholders,2022-03-31 00:00:00,12580000000.0,TATACHEM.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,TATACHEM.NS
Net Income,2022-03-31 00:00:00,12580000000.0,TATACHEM.NS
Minority Interests,2022-03-31 00:00:00,-1470000000.0,TATACHEM.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,14050000000.0,TATACHEM.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,50000000.0,TATACHEM.NS
Net Income Continuous Operations,2022-03-31 00:00:00,14000000000.0,TATACHEM.NS
Tax Provision,2022-03-31 00:00:00,2670000000.0,TATACHEM.NS
Pretax Income,2022-03-31 00:00:00,16670000000.0,TATACHEM.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,390000000.0,TATACHEM.NS
Special Income Charges,2022-03-31 00:00:00,-250000000.0,TATACHEM.NS
Other Special Charges,2022-03-31 00:00:00,70000000.0,TATACHEM.NS
Write Off,2022-03-31 00:00:00,180000000.0,TATACHEM.NS
Impairment Of Capital Assets,2022-03-31 00:00:00,,TATACHEM.NS
Restructuring And Mergern Acquisition,2022-03-31 00:00:00,110400000.0,TATACHEM.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-1880000000.0,TATACHEM.NS
Total Other Finance Cost,2022-03-31 00:00:00,760000000.0,TATACHEM.NS
Interest Expense Non Operating,2022-03-31 00:00:00,2270000000.0,TATACHEM.NS
Interest Income Non Operating,2022-03-31 00:00:00,1150000000.0,TATACHEM.NS
Operating Income,2022-03-31 00:00:00,15380000000.0,TATACHEM.NS
Operating Expense,2022-03-31 00:00:00,76910000000.0,TATACHEM.NS
Other Operating Expenses,2022-03-31 00:00:00,31130000000.0,TATACHEM.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,8060000000.0,TATACHEM.NS
Amortization,2022-03-31 00:00:00,1040000000.0,TATACHEM.NS
Depreciation Income Statement,2022-03-31 00:00:00,7020000000.0,TATACHEM.NS
Selling General And Administration,2022-03-31 00:00:00,22870000000.0,TATACHEM.NS
Selling And Marketing Expense,2022-03-31 00:00:00,22050000000.0,TATACHEM.NS
General And Administrative Expense,2022-03-31 00:00:00,820000000.0,TATACHEM.NS
Rent And Landing Fees,2022-03-31 00:00:00,430000000.0,TATACHEM.NS
Gross Profit,2022-03-31 00:00:00,92290000000.0,TATACHEM.NS
Cost Of Revenue,2022-03-31 00:00:00,32880000000.0,TATACHEM.NS
Total Revenue,2022-03-31 00:00:00,125170000000.0,TATACHEM.NS
Operating Revenue,2022-03-31 00:00:00,125170000000.0,TATACHEM.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,TATACHEM.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,TATACHEM.NS
Normalized EBITDA,2021-03-31 00:00:00,,TATACHEM.NS
Total Unusual Items,2021-03-31 00:00:00,,TATACHEM.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,TATACHEM.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,TATACHEM.NS
Reconciled Depreciation,2021-03-31 00:00:00,,TATACHEM.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,TATACHEM.NS
EBITDA,2021-03-31 00:00:00,,TATACHEM.NS
EBIT,2021-03-31 00:00:00,,TATACHEM.NS
Net Interest Income,2021-03-31 00:00:00,,TATACHEM.NS
Interest Expense,2021-03-31 00:00:00,,TATACHEM.NS
Interest Income,2021-03-31 00:00:00,747600000.0,TATACHEM.NS
Normalized Income,2021-03-31 00:00:00,,TATACHEM.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,TATACHEM.NS
Total Expenses,2021-03-31 00:00:00,,TATACHEM.NS
Rent Expense Supplemental,2021-03-31 00:00:00,519200000.0,TATACHEM.NS
Diluted Average Shares,2021-03-31 00:00:00,254756278.0,TATACHEM.NS
Basic Average Shares,2021-03-31 00:00:00,254756278.0,TATACHEM.NS
Diluted EPS,2021-03-31 00:00:00,10.06,TATACHEM.NS
Basic EPS,2021-03-31 00:00:00,10.06,TATACHEM.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,TATACHEM.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,TATACHEM.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,TATACHEM.NS
Net Income,2021-03-31 00:00:00,,TATACHEM.NS
Minority Interests,2021-03-31 00:00:00,,TATACHEM.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,TATACHEM.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,,TATACHEM.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,TATACHEM.NS
Tax Provision,2021-03-31 00:00:00,,TATACHEM.NS
Pretax Income,2021-03-31 00:00:00,,TATACHEM.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,TATACHEM.NS
Special Income Charges,2021-03-31 00:00:00,,TATACHEM.NS
Other Special Charges,2021-03-31 00:00:00,,TATACHEM.NS
Write Off,2021-03-31 00:00:00,1700000.0,TATACHEM.NS
Impairment Of Capital Assets,2021-03-31 00:00:00,,TATACHEM.NS
Restructuring And Mergern Acquisition,2021-03-31 00:00:00,,TATACHEM.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,TATACHEM.NS
Total Other Finance Cost,2021-03-31 00:00:00,814900000.0,TATACHEM.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,TATACHEM.NS
Interest Income Non Operating,2021-03-31 00:00:00,747600000.0,TATACHEM.NS
Operating Income,2021-03-31 00:00:00,,TATACHEM.NS
Operating Expense,2021-03-31 00:00:00,,TATACHEM.NS
Other Operating Expenses,2021-03-31 00:00:00,,TATACHEM.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,TATACHEM.NS
Amortization,2021-03-31 00:00:00,1175000000.0,TATACHEM.NS
Depreciation Income Statement,2021-03-31 00:00:00,,TATACHEM.NS
Selling General And Administration,2021-03-31 00:00:00,,TATACHEM.NS
Selling And Marketing Expense,2021-03-31 00:00:00,,TATACHEM.NS
General And Administrative Expense,2021-03-31 00:00:00,631700000.0,TATACHEM.NS
Rent And Landing Fees,2021-03-31 00:00:00,519200000.0,TATACHEM.NS
Gross Profit,2021-03-31 00:00:00,,TATACHEM.NS
Cost Of Revenue,2021-03-31 00:00:00,,TATACHEM.NS
Total Revenue,2021-03-31 00:00:00,,TATACHEM.NS
Operating Revenue,2021-03-31 00:00:00,,TATACHEM.NS
